nach oben

Erschienen in:

23.06.2016 | Original Article

Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2

verfasst von: Qiao Li, Pan Chen, Zhaoyang Zeng, Fang Liang, Yali Song, Fang Xiong, Xiayu Li, Zhaojian Gong, Ming Zhou, Bo Xiang, Cong Peng, Xiaoling Li, Xiang Chen, Guiyuan Li, Wei Xiong

Erschienen in: Tumor Biology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Transforming growth factor β-stimulated clone 22 domain family, member 2 (TSC22D2), a member of the TSC22D family, has been implicated as a tumor-associated gene, but its function remains unknown. To further explore its biological role, yeast two-hybrid screening combined with multiple bioinformatics tools was used to identify 44 potential interacting partners of the TSC22D2 protein that were mainly involved in gene transcription, cellular metabolism, and cell cycle regulation. The protein WD repeat domain 77 (WDR77) was selected for further validation due to its function in the cell cycle and tumor development, as well as its high detection frequency in the yeast two-hybrid assay. Immunoprecipitation and immunofluorescence experiments confirmed an interaction between the TSC22D2 and WDR77 proteins. Our work greatly expands the putative protein interaction network of TSC22D2 and provides deeper insight into the biological functions of the TSC22D2 and WDR77 proteins.

Liang F, Zeng Z, Li Q, Li X, Li Z, Gong Z, et al. TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. Int J Oncol. 2016 (in press).

Shibanuma M, Kuroki T, Nose K. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J Biol Chem. 1992;267:10219–24.PubMed

Kester HA, Blanchetot C, den Hertog J, van der Saag PT, van der Burg B. Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J Biol Chem. 1999;274:27439–47.CrossRefPubMed

Fiol DF, Mak SK, Kultz D. Specific TSC22 domain transcripts are hypertonically induced and alternatively spliced to protect mouse kidney cells during osmotic stress. Febs J. 2007;274:109–24.CrossRefPubMed

Ohta S, Yanagihara K, Nagata K. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem J. 1997;324(Pt 3):777–82.CrossRefPubMedPubMedCentral

D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity. 1997;7:803–12.CrossRefPubMed

Dohrmann CE, Belaoussoff M, Raftery LA. Dynamic expression of TSC-22 at sites of epithelial-mesenchymal interactions during mouse development. Mech Dev. 1999;84:147–51.CrossRefPubMed

Gluderer S, Brunner E, Germann M, Jovaisaite V, Li C, Rentsch CA, et al. Madm (Mlf1 adapter molecule) cooperates with Bunched A to promote growth in Drosophila. J Biol. 2010;9:9.CrossRefPubMedPubMedCentral

Canterini S, Bosco A, Carletti V, Fuso A, Curci A, Mangia F, et al. Subcellular TSC22D4 localization in cerebellum granule neurons of the mouse depends on development and differentiation. Cerebellum. 2012;11:28–40.CrossRefPubMed

10.

Beaulieu E, Morand EF. Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat Rev Rheumatol. 2011;7:340–8.CrossRefPubMed

11.

Riccardi C. GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids. Ann Ig. 2010;22:53–9.PubMed

12.

Riccardi C, Zollo O, Nocentini G, Bruscoli S, Bartoli A, D'Adamio F, et al. Glucocorticoid hormones in the regulation of cell death. Therapie. 2000;55:165–9.PubMed

13.

Kawamata H, Nakashiro K, Uchida D, Hino S, Omotehara F, Yoshida H, et al. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br J Cancer. 1998;77:71–8.CrossRefPubMedPubMedCentral

14.

Shostak KO, Dmitrenko VV, Vudmaska MI, Naidenov VG, Beletskii AV, Malisheva TA, et al. Patterns of expression of TSC-22 protein in astrocytic gliomas. Exp Oncol. 2005;27:314–8.PubMed

15.

Iida M, Anna CH, Gaskin ND, Walker NJ, Devereux TR. The putative tumor suppressor Tsc-22 is downregulated early in chemically induced hepatocarcinogenesis and may be a suppressor of Gadd45b. Toxicol Sci. 2007;99:43–50.CrossRefPubMed

16.

Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, et al. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood. 2009;113:5558–67.CrossRefPubMedPubMedCentral

17.

Yoon CH, Rho SB, Kim ST, Kho S, Park J, Jang IS, et al. Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer. Plos One. 2012;7:e42006.CrossRefPubMedPubMedCentral

18.

Nakamura M, Kitaura J, Enomoto Y, Lu Y, Nishimura K, Isobe M, et al. Transforming growth factor-beta-stimulated clone-22 is a negative-feedback regulator of Ras/Raf signaling: implications for tumorigenesis. Cancer Sci. 2012;103:26–33.CrossRefPubMed

19.

Ayroldi E, Zollo O, Bastianelli A, Marchetti C, Agostini M, Di Virgilio R, et al. GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Invest. 2007;117:1605–15.CrossRefPubMedPubMedCentral

20.

Ayroldi E, Petrillo MG, Bastianelli A, Marchetti MC, Ronchetti S, Nocentini G, et al. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells. Cell Death Differ. 2015;22:118–30.CrossRefPubMed

21.

Zhou L, Wu H, Lee P, Wang Z. Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells. J Mol Endocrinol. 2006;37:283–300.CrossRefPubMed

22.

Gao S, Wang Z. Subcellular localization of p44/WDR77 determines proliferation and differentiation of prostate epithelial cells. Plos One. 2012;7:e49173.CrossRefPubMedPubMedCentral

23.

Peng Y, Chen F, Melamed J, Chiriboga L, Wei J, Kong X, et al. Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. Proc Natl Acad Sci U S A. 2008;105:5236–41.CrossRefPubMedPubMedCentral

24.

Liang JJ, Wang Z, Chiriboga L, Greco MA, Shapiro E, Huang H, et al. The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors. J Urol. 2007;177:1918–22.CrossRefPubMed

25.

Ligr M, Patwa RR, Daniels G, Pan L, Wu X, Li Y, et al. Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer. Plos One. 2011;6:e26250.CrossRefPubMedPubMedCentral

26.

Peng Y, Li Y, Gellert LL, Zou X, Wang J, Singh B, et al. Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. J Cell Mol Med. 2010;14:2780–9.CrossRefPubMed

27.

Gu Z, Zhang F, Wang ZQ, Ma W, Davis RE, Wang Z. The p44/wdr77-dependent cellular proliferation process during lung development is re-activated in lung cancer. Oncogene. 2013;32:1888–900.CrossRefPubMed

28.

Spyrou I, Sifakis S, Ploumidis A, Papalampros AE, Felekouras E, Tsatsakis AM, et al. Expression profile of CYP1A1 and CYP1B1 enzymes in endometrial tumors. Tumor Biol. 2014;35:9549–56.CrossRef

29.

Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X, et al. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumor Biol. 2015.

30.

Liu XF, Bera TK, Kahue C, Escobar T, Fei Z, Raciti GA, et al. ANKRD26 and its interacting partners TRIO, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cells. Plos One. 2012;7:e38130.CrossRefPubMedPubMedCentral

31.

Chai Y, Liu X, Dai L, Li Y, Liu M, Zhang JY. Overexpression of HCC1/CAPERalpha may play a role in lung cancer carcinogenesis. Tumor Biol. 2014;35:6311–7.CrossRef

32.

Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL. NCBI BLAST: a better web interface. Nucleic Acids Res. 2008;36:W5–9.CrossRefPubMedPubMedCentral

33.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.CrossRefPubMedPubMedCentral

34.

Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, Boucher L, Heinicke S, Chen D, et al. The BioGRID interaction database: 2015 update. Nucleic Acids Res. 2015;43:D470–8.CrossRefPubMed

35.

Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, Galeota E, et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 2012;40:D857–61.CrossRefPubMed

36.

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52.CrossRefPubMed

37.

Mitchell A, Chang HY, Daugherty L, Fraser M, Hunter S, Lopez R, et al. The InterPro protein families database: the classification resource after 15 years. Nucleic Acids Res. 2015;43:D213–21.CrossRefPubMed

38.

Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.CrossRef

39.

Safran M, Dalah I, Alexander J, Rosen N, Iny ST, Shmoish M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010;2010:q20.CrossRef

40.

Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A. 2001;98:4569–74.CrossRefPubMedPubMedCentral

41.

Formstecher E, Aresta S, Collura V, Hamburger A, Meil A, Trehin A, et al. Protein interaction mapping: a Drosophila case study. Genome Res. 2005;15:376–84.CrossRefPubMedPubMedCentral

42.

Riccardi C, Bruscoli S, Ayroldi E, Agostini M, Migliorati G. GILZ, a glucocorticoid hormone induced gene, modulates T lymphocytes activation and death through interaction with NF-kB. Adv Exp Med Biol. 2001;495:31–9.CrossRefPubMed

43.

Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol. 2002;22:7929–41.CrossRefPubMedPubMedCentral

44.

Vago JP, Tavares LP, Garcia CC, Lima KM, Perucci LO, Vieira EL, et al. The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution. J Immunol. 2015;194:4940–50.CrossRefPubMed

45.

Wilson CH, Crombie C, van der Weyden L, Poulogiannis G, Rust AG, Pardo M, et al. Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation. Embo J. 2012;31:2486–97.CrossRefPubMedPubMedCentral

46.

Ruiz C, Oeggerli M, Germann M, Gluderer S, Stocker H, Andreozzi M, et al. High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. Prostate. 2012;72:1678–87.CrossRefPubMed

47.

Kerr JS, Wilson CH. Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase. Biochem Soc Trans. 2013;41:1055–60.CrossRefPubMed

48.

Hilt W, Wolf DH. Proteasomes: destruction as a programme. Trends Biochem Sci. 1996;21:96–102.CrossRefPubMed

49.

Smith DK, Xue H. Sequence profiles of immunoglobulin and immunoglobulin-like domains. J Mol Biol. 1997;274:530–45.CrossRefPubMed

50.

Bateman A, Sandford R. The PLAT domain: a new piece in the PKD1 puzzle. Curr Biol. 1999;9:R588–90.CrossRefPubMed

51.

Gamsjaeger R, Liew CK, Loughlin FE, Crossley M, Mackay JP. Sticky fingers: zinc-fingers as protein-recognition motifs. Trends Biochem Sci. 2007;32:63–70.CrossRefPubMed

52.

Hino S, Kawamata H, Uchida D, Omotehara F, Miwa Y, Begum NM, et al. Nuclear translocation of TSC-22 (TGF-beta-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator. Biochem Biophys Res Commun. 2000;278:659–64.CrossRefPubMed

53.

Friesen WJ, Wyce A, Paushkin S, Abel L, Rappsilber J, Mann M, et al. A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem. 2002;277:8243–7.CrossRefPubMed

54.

Antonysamy S, Bonday Z, Campbell RM, Doyle B, Druzina Z, Gheyi T, et al. Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci U S A. 2012;109:17960–5.CrossRefPubMedPubMedCentral

55.

Ho MC, Wilczek C, Bonanno JB, Xing L, Seznec J, Matsui T, et al. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity. Plos One. 2013;8:e57008.CrossRefPubMedPubMedCentral

56.

Yi P, Gao S, Gu Z, Huang T, Wang Z. P44/WDR77 restricts the sensitivity of proliferating cells to TGFbeta signaling. Biochem Biophys Res Commun. 2014;450:409–15.CrossRefPubMed

57.

Choi SJ, Moon JH, Ahn YW, Ahn JH, Kim DU, Han TH. Tsc-22 enhances TGF-beta signaling by associating with Smad4 and induces erythroid cell differentiation. Mol Cell Biochem. 2005;271:23–8.CrossRefPubMed

58.

Uchida D, Omotehara F, Nakashiro K, Tateishi Y, Hino S, Begum NM, et al. Posttranscriptional regulation of TSC-22 (TGF-beta-stimulated clone-22) gene by TGF-beta 1. Biochem Biophys Res Commun. 2003;305:846–54.CrossRefPubMed

59.

Gupta RA, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, et al. Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem. 2003;278:7431–8.CrossRefPubMed

Titel: Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2
verfasst von: Qiao Li
Pan Chen
Zhaoyang Zeng
Fang Liang
Yali Song
Fang Xiong
Xiayu Li
Zhaojian Gong
Ming Zhou
Bo Xiang
Cong Peng
Xiaoling Li
Xiang Chen
Guiyuan Li
Wei Xiong
Publikationsdatum: 23.06.2016
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 9/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5113-z

Springer Medizin

Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2016

Note of the methodological flaws in the paper entitled “GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis”

Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy

Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China

Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression

Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium

Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie